Manchikanti Laxmaiah, Giordano James, Boswell Mark V, Fellows Bert, Manchukonda Rajeev, Pampati Vidyasagar
Pain Management Center of Paducab, Kentucky, USA.
J Opioid Manag. 2007 Mar-Apr;3(2):89-100. doi: 10.5055/jom.2007.0045.
Psychopathology (depression, anxiety, somatization disorder) and substance abuse (opioid misuse and illicit drug use) are common in patients with chronic pain and present problems for public health and clinical management. Despite a body of literature describing various methods for identifying psychopathology, opioid misuse, and illicit drug use in chronic pain patients, the relationship between psychopathologies, substance abuse, and chronic pain has not been well characterized.
This report describes a total of 500 consecutive pain patients prescribed and receiving stable doses of opioids. The patients were evaluated for psychopathology, opioid abuse, and illicit drug use during the course of regular pain management treatment. The relationships between psychopathology and drug abuse and/or illicit drug use in chronic pain patients were examined, and psychological evaluation for depression, anxiety, and somatization disorder was performed.
Depression, anxiety, and somatization disorder were documented in 59, 64, and 30 percent of chronic pain patients, respectively. Drug abuse was significantly higher in patients with depression as compared to patients without depression (12 percent with depression versus 5 percent without). Current illicit drug use was higher in women with depression (22 percent) than women without depression (14 percent) and in men with or without depression (12 percent). Current illicit drug use was also higher in men with somatization disorder (22 percent) than men without (9 percent).
This study demonstrated that the presence of psychological features of depression and somatization disorder may be markers of substance abuse diathesis in chronic pain patients.
精神病理学(抑郁症、焦虑症、躯体化障碍)和药物滥用(阿片类药物滥用及非法药物使用)在慢性疼痛患者中很常见,给公共卫生和临床管理带来诸多问题。尽管有大量文献描述了识别慢性疼痛患者精神病理学、阿片类药物滥用及非法药物使用的各种方法,但精神病理学、药物滥用与慢性疼痛之间的关系尚未得到充分描述。
本报告描述了总共500名连续的正在服用并接受稳定剂量阿片类药物的疼痛患者。在常规疼痛管理治疗过程中,对这些患者进行精神病理学、阿片类药物滥用及非法药物使用方面的评估。研究慢性疼痛患者中精神病理学与药物滥用和/或非法药物使用之间的关系,并对抑郁症、焦虑症和躯体化障碍进行心理评估。
分别有59%、64%和30%的慢性疼痛患者被诊断患有抑郁症、焦虑症和躯体化障碍。与无抑郁症的患者相比,抑郁症患者的药物滥用情况显著更高(抑郁症患者中为12%,无抑郁症患者中为%)。患有抑郁症的女性当前非法药物使用率(22%)高于无抑郁症的女性(14%),男性无论是否患有抑郁症当前非法药物使用率均为12%。患有躯体化障碍的男性当前非法药物使用率(22%)也高于无躯体化障碍的男性(9%)。
本研究表明,抑郁症和躯体化障碍的心理特征可能是慢性疼痛患者药物滥用易感性的标志。